Corcept Therapeutics Stock Performance
as on September 19, 2026 at 2:15 pm IST
Day's Low
Day's High
$108.41$117.90
1.70%
Downside
6.90%
Upside
52 Week's Low
52 Week's High
$28.66$126.3874.01%
Downside
14.59%
Upside
Corcept Therapeutics share price movements today
- Previous Close
- $114.86
- Open
- $117.22
- Volume
- 1.8M
- Market Cap
- $12.4B
- Day's Low - High
- $108.41 - $117.90
- 52 Week Low - High
- $28.66 - $126.38
Corcept Therapeutics Historical Returns
- 1 Month Return
- -3.5 %
- 3 Month Return
- + 43.74 %
- 1 Year Return
- + 42.65 %
- 3 Year Return
- + 248.38 %
- 5 Year Return
- + 460.02 %
Corcept Therapeutics Stock Fundamentals & Key Indicators
Check Corcept Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$12.4B
EPS (TTM)
0.52
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
220.88
Industry PE ratio
11.41
PEG Ratio
-3.7610083160083154
EBITDA
28.8M
Revenue (TTM)
830.8M
Profit Margin
98.30%
Return On Equity TTM
8.37%
Corcept Therapeutics Stock Valuation
Track how Corcept Therapeutics P/E has moved over time to understand its valuation trends.
Corcept Therapeutics in the last 5 years
Lowest (20.35x)
December 31, 2021
Industry (11.41x)
December 31, 2025
Today (36.63x)
December 31, 2025
Highest (37.23x)
December 31, 2024
Today’s Price to Earnings Ratio: 36.63x
Corcept Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Corcept Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $12.4B | 460.02% | 220.88 | 98.30% | 0.00% | |
| BUY | $63.1B | -63.24% | -19.81 | -12.57% | 0.00% | |
| BUY | $130.1B | 174.21% | 29.81 | 86.04% | 0.00% | |
| BUY | $79.7B | 21.1% | 18.48 | 84.86% | 0.48% |
Stock Returns calculator for Corcept Therapeutics Stock including INR - Dollar returns
The Corcept Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Corcept Therapeutics investment value today
Current value as on today
₹1,48,725
Returns
₹48,725
(+48.73%)
Returns from Corcept Therapeutics Stock
₹36,972 (+36.97%)
Dollar Impact
₹11,753 (+11.75%)
Analyst Recommendation on Corcept Therapeutics Stock
Based on 5 analysts
80.00%
Buy
0.00%
Hold
20.00%
Sell
Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for Corcept Therapeutics. Average target price of $141
Corcept Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Corcept Therapeutics.
What analysts predicted
21.78%UPSIDE
Target Price
$141
Current Price
$110.29
Analyzed by
5 Analysts
Target
$141.00
Corcept Therapeutics target price $141, a slight upside of 21.78% compared to current price of $110.29. According to 5 analysts rating.
Indian Investors' Interest in Corcept Therapeutics Stock
Search interest for Corcept Therapeutics Stock has decreased by -49% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Corcept Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Corcept Therapeutics Annual Profit & Loss
All numbers in Millions USD
Corcept Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Corcept Therapeutics Annual Cash Flow
All numbers in Millions USD
Corcept Therapeutics News & Key Events
Today's Timeline - 30 July
Thu, 12:18 PM
-Corcept Therapeutics reports Q2 earnings of $0.36, beating estimates, and raises 2026 revenue guidance to $1.1-$1.2 billion.
Thu, 09:32 PM
-Corcept's stock soars 22% after hours following strong Q2 results and raised revenue guidance.
Insights on Corcept Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 3 Years
In the last 3 years, CORT has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Price Rise
In the last 6 months, CORT stock has moved up by 218.4%
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -31.20M → 42.14M (in $), with an average increase of 174.0% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 164.90M → 256.14M (in $), with an average increase of 35.6% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 510.3% return, outperforming this stock by 473.3%
About Corcept Therapeutics
| Organisation | Corcept Therapeutics |
| Headquarters | 101 Redwood Shores Parkway, Redwood City, CA, 94065, US |
| Industry | Medical - Pharmaceuticals |
| CEO | Joseph K. Belanoff |
| E-voting on shares | Click here to vote |
Key Management of Corcept Therapeutics
Name | Title |
|---|---|
Ms. Amy Flood | Chief Human Resources & Communications Officer |
Mr. Roberto W. Vieira | President of Oncology |
Mr. Atabak Mokari | CFO & Treasurer |
Dr. William Guyer Pharm.D. | Chief Development Officer |
Mr. Gary Charles Robb J.D. | Chief Business Officer & Secretary |
Mr. Joseph Douglas Lyon | Chief Technology & Accounting Officer |
Dr. Joseph K. Belanoff M.D. | Co-Founder, President, CEO & Director |
Mr. Sean Maduck | President of Endocrinology |
Dr. Hazel Hunt Ph.D. | Chief Scientific Officer |
Ms. Monica Tellado | President of Emerging Markets |
FAQs
What is Corcept Therapeutics share price today?
Corcept Therapeutics share price today is $110.29 as on at the close of the market. Corcept Therapeutics share today touched a day high of $117.90 and a low of $108.41.
What is the 52 week high and 52 week low for Corcept Therapeutics share?
Corcept Therapeutics share touched a 52 week high of $126.38 on and a 52 week low of $28.66 on . Corcept Therapeutics stock price today i.e. is closed at $110.29,which is 12.73% down from its 52 week high and 284.82% up from its 52 week low.
What is Corcept Therapeutics's market capitalisation today?
Corcept Therapeutics market capitalisation is $0.01T as on .
How to invest in Corcept Therapeutics Stock (CORT) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Corcept Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Corcept Therapeutics Shares that will get you 0.0136 shares as per Corcept Therapeutics share price of $110.29 per share as on September 19, 2026 at 8:45 am IST.
What is the minimum amount required to buy Corcept Therapeutics Stock (CORT) from India?
Indian investors can start investing in Corcept Therapeutics (CORT) shares with as little as ₹95.88 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.80 in Corcept Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Corcept Therapeutics share’s latest price of $110.29 as on September 19, 2026 at 8:45 am IST, you will get 0.0907 shares of Corcept Therapeutics. Learn more about
fractional shares .
What are the returns that Corcept Therapeutics has given to Indian investors in the last 5 years?
Corcept Therapeutics stock has given 460.02% share price returns and 30.25% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?